Diaverum is one of the world’s leading providers of renal care. The company currently operates in 20 countries and serves a patient base of more than 26 000 people, with a strong position in Europe and Latin America.
The Brazilian health system is very complex and difficult to understand, even for Brazilians, as it is loaded with excessive regulation and norms issued by Anvisa, the Brazilian Sanitary Surveillance Agency. Nonetheless, the public health system, known as SUS (Single Health System), has a confusing structure for payment of health care services provided. SUS is responsible for setting the reimbursement value and paying for services performed by private institutions to the people within the public system. Therefore, Diaverum contacted Business Sweden in order to understand the health system structure in Brazil, as well as to evaluate the renal care market size.
from market prospect to establishment in Brazil
Diaverum and Business Sweden’s first project involved a deep market analysis, with an overview of the number of renal patients as well as current public and private care providers, and the identification of major stakeholders acting as regulators or operators in the sector, besides a regulatory overview.
Upon this analysis, Diaverum concluded that entering Brazil was a smart next step for the company’s expansion in Latin America. The delivery of the project came with good news; the Brazilian government passed a new legislation allowing foreign companies to invest in the local health sector and provide care services, which was previously forbidden.
With success from this partnership, Business Sweden and Diaverum cooperated in other projects such as staff recruitment, rent of office space in Business Sweden’s facility in São Paulo and the introduction to the Business Sweden’s health care network, which gave Diaverum direct access to institutions like Anvisa, the Ministry of Health and the Private Hospitals Association (Anahp).
Further on, Business Sweden also supported Diaverum in analyzing potential acquisitions in Brazil. The project identified key factors for the operation of local renal care clinics in order for Diaverum to select the best candidates.
“Diaverum is very satisfied with the service provided by Business Sweden in Brazil, like many other of Business Sweden’s collaborations around the world. Business Sweden has a broad expertise which extends even to recruitment projects, and we have experienced that this has been handled very effective” - Marie Sjödahl, Area Director Latin America.
Healthcare Network initiative in Brazil
Business Sweden’s health care network is a collaboration between the Swedish Embassy and Business Sweden. The network is a platform to identify and take action against obstacles faced by Swedish companies in the Brazilian health sector. Business Sweden operates as an intermediary to various governmental and regulatory institutions such as: Ministry of Health, Anvisa and the Agency of Private Health Insurance (ANS). In the private sector, the group of Swedish companies also has the opportunity to interact with relevant players like large private hospitals, e.g. Sirio Libanês, Albert Einstein and HCor, and health insurance companies, e.g. Amil, Bradesco and Sulamérica. The network has its base on the platform called Symbio Care - Health by Sweden – and organizes events such as seminars regularly.
For more information about Diaverum, please access https://www.diaverum.com/